Patent · US Active

Compounds

US7855218B2 · kind B2 · utility

11Cited by

4References

16Claims

0Family size

Assignee

Convergence Pharmaceuticals Limited · GB

Inventors

Giuseppe Alvaro · Stevenage, GB
Daniele Andreotti · Verona, IT
Markus Bergauer · Verona, IT
Riccardo Giovannini · Verona, IT
Agostino Marasco · Verona, IT

Key dates

Filing date	Oct 6, 2006
Grant date	Dec 21, 2010
Priority date	—
Expiry date	Nov 14, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) wherein the variables are defined herein, pharmaceutical compositions thereof and methods for treatment using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.